SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.81-0.3%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Manly who wrote (7899)6/11/1999 8:01:00 PM
From: Libbyt  Read Replies (1) of 9523
 
I would have to agree with the message from Manly....this is a great time to be buying PFE.

" Aging population, cheap share prices, best pipeline, best longevity of products, 3 for 1 split approaching, PFE employees buying into their 401K plans, employees just issued options to buy more. Don't let the analysts scare you out of PFE, I work for a competing company and own the same amount of shares as both!"

I would also agree with John Dowd, that the "standard of care" for the medical community would be to not use Trovan as a first choice drug, to use this drug only in a hospital setting, and to use the drug only when other options have been tried. I think there has been too much overreaction to the news on Trovan.... a great time to buy PFE.
Libbyt
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext